Michael Brochu has joined the operating committee of BelHealth Investment Partners. Brochu was most recently the and CEO of Global Market Insite.
BelHealth Investment Partners, LLC (“BelHealth”) today announced that Michael Brochu has joined the Operating Committee.
Mr. Brochu is a technology executive with over 20 years of senior-level experience at a variety of global companies. Most recently, he was the President and CEO of Global Market Insite, developer of technology platforms serving the market research industry. The company was acquired by WPP this past September. Prior to that he served as the President and CEO of Loudeye Corporation, a global leader of digital music platforms and digital media distribution services, which Nokia acquired in 2006. Before Loudeye, Mr. Brochu was President and CEO of Primus Knowledge Solutions, Inc., a provider of e-service software solutions, which he took public in 1999 and in 2004, facilitated the acquisition of the company by Art Technology Group. Mr. Brochu was Executive Chairman of OnHealth Networks from 1997 until it was sold to WebMD in 2000. Previously, Mr. Brochu served as the President and COO of Sierra On-Line, Inc., a publisher of interactive entertainment, educational, and home productivity software. There, he spearheaded efforts that increased sales by more than 300 percent, culminating with the sale of Sierra On-Line to CUC International for US$1.1 billion in 1996. Mr. Brochu currently sits on the board of directors of Centro Digital Media, Vines of Mendoza, Zotec Partners, GraphOn Inc., and the advisory board of Seattle-based venture capital firm Voyager Capital, which is also one of GMI’s early institutional investors. Mr. Brochu was named Ernst & Young’s Entrepreneur of the Year in 2000.
The members of BelHealth’s Operating Committee are accomplished executives with significant experience in managing and growing healthcare companies. The Operating Committee will provide the Fund’s portfolio companies with disciplined leadership and strategic planning to realize maximum growth potential. Dennis Drislane, Chairman of BelHealth’s Operating Committee, said “Mike brings tremendous experience and insight to BelHealth, particularly in the area of technology platforms and software. He adds to the depth of the BelHealth team as an entrepreneur, investor and operator of technology businesses and will contribute greatly to our efforts to enhance value at BelHealth’s portfolio companies.”
Regarding his appointment, Mr. Brochu stated, “I am excited to join the BelHealth team and I look forward to working with Dennis and our other partners to aggressively identify great investment opportunities and help bring value to our portfolio. I believe this is an excellent time to invest in healthcare technology as the industry catches up with others in implementing tools to reduce cost, increase efficiency and eliminate errors and waste.”
About BelHealth Investment Partners
BelHealth Investment Partners is a private equity buyout firm focused exclusively on the small-cap healthcare industry. BelHealth acquires majority positions in healthcare companies that the BelHealth Team believes are undervalued or undermanaged and would benefit from the vast entrepreneurial and operating experience that BelHealth can deliver. BelHealth’s target sectors within healthcare include Healthcare Services, Healthcare Information Technology and Healthcare Products and Distribution. The fund typically invests between $10 – 25 million per platform company. Applying an active, hands-on approach to governance, BelHealth utilizes its experience to drive revenue and profit growth and achieve superior returns for its investors. For more information about BelHealth, please go to its website: www.BelHealth.com.